Pharma Focus America

Thermo Fisher Scientific Expands Clinical Research Facility in Kentucky

Friday, June 28, 2024

Thermo Fisher Scientific Inc.'s PPD clinical research division has announced a significant expansion of its central laboratory operations in Kentucky, aimed at supporting pharmaceutical and biotech companies in delivering safe and effective medicines to patients more efficiently.

The expansion involves the establishment of a new 65,000-square-foot facility in Covington, alongside enhancing capabilities at its existing site in Highland Heights. This $47.8 million investment is projected to create over 250 new jobs across both locations over the next eight years, with construction slated to commence later this year.

Since 2002, PPD's central lab in Highland Heights has provided critical services including central lab operations, biomarker testing, and sample management for a range of therapeutics, including vaccines and cell and gene therapies. The expansion into Covington will significantly increase lab space, supporting the company's global efforts to advance life-changing research.

Leon Wyszkowski, President of Analytical Services at Thermo Fisher Scientific, emphasized the role of these expansions in helping customers make informed decisions during clinical trials and ensuring patient safety. The company plans to continue hiring talented professionals to bolster its capabilities in Kentucky, with strong support from state and local officials.

Governor Andy Beshear highlighted Kentucky's growing healthcare and life sciences sectors, noting that Thermo Fisher's continued investment will provide high-quality jobs for residents. The Highland Heights facility, currently employing over 600 staff including scientists and support professionals, offers a wide array of services such as safety testing, biomarker analysis, and clinical sample management.

In addition to its Kentucky facilities, Thermo Fisher's clinical research business operates labs in various global locations, including Brussels, Singapore, Virginia, Wisconsin, Ireland, and China, reinforcing its commitment to supporting global health initiatives through advanced laboratory services.

 

Source: businesswire.com

Thermo Fisher Scientific - mRNA ServicesFuture Labs Live USA 2024World Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies USA 2024World Orphan Drug Congress Europe 2024